Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2026 Feb 25;63(1):469.
doi: 10.1007/s12035-026-05737-8.

Hippocampal Neuronal Ferroptosis Driven by Lipocalin-2 Mediates Comorbid Visceral Pain and Anxiety in Irritable Bowel Syndrome

Affiliations

Hippocampal Neuronal Ferroptosis Driven by Lipocalin-2 Mediates Comorbid Visceral Pain and Anxiety in Irritable Bowel Syndrome

Ying Tang et al. Mol Neurobiol. .

Abstract

Irritable bowel syndrome (IBS) is characterized by chronic visceral pain and anxiety comorbidity, yet the central mechanisms linking gut signals to persistent pain-emotion dysregulation remain unclear. This study investigated whether hippocampal Lipocalin-2 (LCN2) drives neuronal ferroptosis to mediate visceral hypersensitivity and anxiety-like behaviors in a neonatal rat IBS model. Using a colorectal distension model, we conducted behavioral tests, molecular assays, and electron microscopy. IBS-like rats exhibited upregulated hippocampal LCN2 expression, predominantly in neurons, alongside ferroptosis hallmarks including increased ACSL4, decreased GPX4, elevated Fe2⁺ and MDA levels, and mitochondrial damage. Inhibition of ferroptosis reversed visceral pain and anxiety-like behaviors. LCN2 knockdown in the hippocampal CA1 region alleviated IBS-related phenotypes, while LCN2 overexpression in normal rats induced similar behavioral and ferroptotic changes. These findings identify a novel LCN2-ferroptosis axis in hippocampal neurons that critically mediates gut-brain dysregulation in IBS. Our study provides the first causal evidence linking LCN2-driven ferroptosis to visceral pain-anxiety comorbidity, offering new mechanistic insights and potential therapeutic targets for IBS and related gut-brain disorders.

Keywords: Anxiety; Ferroptosis; Gut–brain axis; Hippocampus; Irritable bowel syndrome; Lipocalin-2.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics Approval: The experimental protocol regarding animals was reviewed and approved by the Animal Welfare & Ethics Committee of Fujian Medical University (FJMU-IACUC-2023-Y-1044). Consent to Participate: Not applicable Consent for Publication: Not applicable Conflict of interest: The authors declare no competing interests.

References

    1. Chey WD, Kurlander J, Eswaran S (2015) Irritable bowel syndrome: a clinical review. JAMA 313:949–958. https://doi.org/10.1001/jama.2015.0954 - DOI - PubMed
    1. Ford AC, Sperber AD, Corsetti M, Camilleri M (2020) Irritable bowel syndrome. Lancet 396:1675–1688. https://doi.org/10.1016/S0140-6736(20)31548-8 - DOI - PubMed
    1. Pellegrino R, Gravina AG (2025) Irritable bowel syndrome remains a complex disorder of gut-brain interaction: too many actors on stage. World J Gastroenterol 31:101357. https://doi.org/10.3748/wjg.v31.i8.101357 - DOI - PubMed - PMC
    1. Mayer EA, Nance K, Chen S (2022) The gut-brain axis. Annu Rev Med 73:439–453. https://doi.org/10.1146/annurev-med-042320-014032 - DOI - PubMed
    1. Mayer EA, Ryu HJ, Bhatt RR (2023) The neurobiology of irritable bowel syndrome. Mol Psychiatry 28:1451–1465. https://doi.org/10.1038/s41380-023-01972-w - DOI - PubMed - PMC

MeSH terms